Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000770

Type of data
NGS (RNA-seq, scRNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
19.8 GB
File formats
  • FASTQ
Research
hum0358
Date published
2023-10-12
Date modified
2023-10-12

Analysis method

RNA-seq

Materials and participants
cervical cancer (ICD10: C539)
3 cases: 3 samples of normal cervical tissue-derived organoids
1 case: 4 samples of normal cervical tissue

siRNA-mediated knockdown samples of NIKS18 cell line
siNPM3: 2 samples, siNC: 3 samples
  • Health status
    Mixed
  • Subject count
    23 (Individual)
Disease
cervical cancer (C539)
Sample description
RNAs extracted from tumor tissues, non-tumor tissues, patient-derived organoids, or siRNA-mediated knockdown samples of NIKS18
  • Tissue
    Organoid
  • Tumor / normal
    Mixed
Cell line
NIKS18
Sample provider
NIKS18 is NIKS, which is a human keratinocyte cell line (ATCC CRL-12191), contain HPV18 genome as episomes
Experimental method
RNA-seq
Target
N/A
Reagent kit
Nextera XT DNA Library Prep Kit
Fragmentation
Nextera XT transposome
Platform
Illumina MiSeq
Read type
Paired-end
Read length
75 bp

scRNA-seq

Materials and participants
cervical cancer (ICD10: C539)
1 case: 50 cells of normal cervical tissue-derived organoids
  • Health status
    Mixed
  • Subject count
    1 (Individual)
Disease
cervical cancer (C539)
Sample description
RNAs extracted from cells of normal cervical tissue-derived organoids
  • Tissue
    Organoid
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
scRNA-seq
Target
N/A
Reagent kit
Nextera XT DNA Library Prep Kit
Fragmentation
Nextera XT transposome
Platform
Illumina MiSeq
Read type
Paired-end
Read length
75 bp